WO2019225755A1

WO2019225755A1 - Deodorant and deactivating agent

Info

Publication number: WO2019225755A1
Application number: PCT/JP2019/020760
Authority: WO
Inventors: 落合　正敏; 雅子勝山
Original assignee: 株式会社資生堂
Priority date: 2018-05-25
Filing date: 2019-05-24
Publication date: 2019-11-28
Also published as: CN112203631B; JPWO2019225755A1; TW202002936A; CN112203631A; JP7485597B2

Abstract

Provided are: a deodorant for deodorizing stress odor; and a deactivating agent for deactivating psychological or mental activity induced by stress odor. The deodorant and the deactivating agent contain at least one among a first deodorant component and a second deodorant component. The first deodorant component includes at least one selected from a first group consisting of silver-supported zeolite, tocopherol, zinc oxide, Cassumunar extract, Lempuyang extract, and combinations thereof. The second deodorant component includes at least one selected from a second group consisting of laponite, silver-supported zeolite, zinc oxide, Neem leaf extract, iris root extract, perilla leaf extract, hydroxypropyl-β-cyclodextrin, Hedychium Spicatum extract, tocopherol, and combinations thereof.

Description

Deodorant and deactivator

Related applications

The present invention is based on the priority claim of Japanese patent application: Japanese Patent Application No. 2018-100599 (filed on May 25, 2018), the entire contents of which are incorporated herein by reference. Shall.

The present disclosure relates to a deodorant that eliminates or reduces discomfort caused by body odor. The present disclosure relates to an inactivating agent that inactivates a physiological / psychological activity (modulation) action by a secretory component from a human body.

Many of the odors caused by odorous components emitted from human skin are unpleasant odors and are generally called “body odors”. For example, “aging odor” is known as a body odor peculiar to middle-aged and elderly people (see, for example, Patent Document 1). In order to eliminate the unpleasantness due to the aging odor, the aging odor suppressing fragrance composition described in Patent Document 1 has a component excellent in the masking effect on the aging odor and / or a component excellent in the harmony effect on the aging odor. It is blended.

In general, sulfur compounds are considered to be unpleasant odor components. Patent Document 2 discloses at least one selected from the group consisting of butyl 2-methylbutanoate, α-terpinene, dipentene, cis-4-heptenal, 1,4-cineole, trimethylhexylaldehyde, and (+)-limonene oxide. An inhibitor of the odor of a polysulfide compound is disclosed which contains as an active ingredient.

Japanese Patent Laid-Open No. 11-286428 WO2016 / 204212A1

The present inventors have noticed that there is a peculiar smell around a person who is in a tension state (stress state) in which the heart rate increases due to mental stress. Therefore, the present inventors have studied the cause of the odor. The odor is a body odor caused by a substance secreted / released from a person in a tension state or a mental stress state (hereinafter referred to as “tension” in this disclosure). Odor "or" stress odor ").

This tension odor is a sulfur-based odor that many people will feel uncomfortable. In recent years, interest in body odor has increased, and it is expected that demand for deodorants that can eliminate or reduce discomfort caused by tension odor will increase.

The odor suppressor described in Patent Document 2 refers only to bad odors other than the human body such as drain outlets and garbage, and has not been studied for bad odors emitted from the human body, and the odor described in Patent Document 2 It is unclear whether the suppressor can suppress the tension odor.

The present inventor believes that a component secreted and released from a person who is in a tension state or mental stress state (for example, a causative substance of a tension odor) has at least one of a physiologically active action and a psychologically active action. thinking. Therefore, for an inactive agent that inactivates a physiologically active action and / or a psychologically active action by a component secreted from a person in tension or mental stress (hereinafter referred to as “tension odor component”). Demand is expected to increase.

According to the first aspect of the present disclosure, a tension odor deodorant containing at least one of the first deodorant component and the second deodorant component is provided. The first deodorizing component includes at least one selected from the first group consisting of silver-supported zeolite, tocopherol, zinc oxide, Camsnar extract, Lumpuyan extract, and combinations thereof. The second deodorant component is composed of laponite, silver supported zeolite, zinc oxide, neem leaf extract, iris root extract, perilla leaf extract, hydroxypropyl-β-cyclodextrin, sanna extract, tocopherol, and combinations thereof. Including at least one selected from the group.

According to the second aspect of the present disclosure, a tension odor deodorant containing at least one of the first deodorant component and the second deodorant component is provided. The first deodorizing component includes at least one selected from the first group consisting of silver-supported zeolite, tocopherol, zinc oxide, Camsnar extract, Lumpuyan extract, and combinations thereof. The second deodorant component is zinc oxide, laponite, silver-supported zeolite, dibutylhydroxytoluene, sugarcane extract, loquat leaf extract, iris root extract, perilla leaf extract, hydroxypropyl-β-cyclodextrin, sanna extract, green tea extract, And at least one selected from the third group consisting of combinations thereof.

According to the third aspect of the present disclosure, an inactivating agent including at least one of the first deodorizing component and the second deodorizing component is provided. The first inactivating component includes at least one selected from the first group consisting of silver-supported zeolite, tocopherol, zinc oxide, Camsnar extract, Lumpuyan extract, and combinations thereof. The second inactivating component is composed of laponite, silver-supported zeolite, zinc oxide, neem leaf extract, iris root extract, perilla leaf extract, hydroxypropyl-β-cyclodextrin, sanna extract, tocopherol, and combinations thereof. At least one selected from the group of: Inactivators inactivate the psychological or psychoactive activity of secretory components.

According to the fourth aspect of the present disclosure, an inactivating agent including at least one of the first deodorant component and the second deodorant component is provided. The first deactivator component includes at least one selected from the first group consisting of silver-supported zeolite, tocopherol, zinc oxide, camsnar extract, lumpyan extract, and combinations thereof. The second deactivator component is zinc oxide, laponite, silver supported zeolite, dibutylhydroxytoluene, sugarcane extract, loquat leaf extract, iris root extract, perilla leaf extract, hydroxypropyl-β-cyclodextrin, sanna extract, green tea And at least one selected from a third group consisting of extracts and combinations thereof. Inactivators inactivate the psychological or psychoactive activity of secretory components.

</ RTI> According to the deodorant of the present disclosure, it is possible to eliminate or reduce discomfort based on a tension odor.

According to the inactivating agent of the present disclosure, it is possible to inactivate or suppress the psychological or physiological activity action by the tension odor component.

The graph which shows the result in Example 4.

Favorable forms from the above viewpoints are described below.

According to the preferred embodiments of the first and second aspects, the tension odor is an odor emitted from the body due to a tension state and / or mental stress.

According to a preferred form of the first and second aspects, the causative substance of the tension odor includes at least one of allyl mercaptan and dimethyl trisulfide.

According to a preferred form of the first and second aspects, the causative substance further contains at least one compound selected from the group consisting of methyl mercaptan, dimethyl sulfide, dimethyl disulfide, and combinations thereof.

According to a preferred form of the first and second aspects, the causative substance further includes 1-octen-3-one.

According to a preferred form of the third and fourth viewpoints, the secretory component is a component secreted from the body due to tension and / or mental stress.

According to a preferred form of the third and fourth aspects, the secretory component contains at least one of allyl mercaptan and dimethyl trisulfide.

According to a preferred form of the third and fourth aspects, the secretory component further contains at least one compound selected from the group consisting of methyl mercaptan, dimethyl sulfide, dimethyl disulfide, and combinations thereof.

According to a preferred form of the third and fourth aspects, the secretory component further contains 1-octen-3-one.

Deodorant according to the first embodiment of the present disclosure will be described.

The deodorant of the present disclosure is a deodorant that can be suitably applied to body odor (tension odor) emitted when a person is in a tension state and / or a mental stress state. The deodorant in the present disclosure refers to a substance that removes or reduces malodor by a chemical action and / or a physical action on a causative substance of a smell to be deodorized (hereinafter referred to as “bad odor”). In addition, even if the components listed in the present disclosure remove or mitigate malodors other than by chemical action and / or physical action, they do not fall outside the scope of the deodorant of the present disclosure.

The deodorizer of the present disclosure includes at least one of a first deodorant component and a second deodorant component.

The first deodorant component can include at least one selected from the first group consisting of silver-supported zeolite, tocopherol, zinc oxide (powder), Kamsnar extract, Lumpuyan extract, and combinations thereof. The first deodorant component is considered to be useful for deodorizing malodor caused by allyl mercaptan among causative substances of tension odor.

In the present disclosure, the silver-supported zeolite includes, for example, one in which at least a part of ion-exchangeable ions in the zeolite is replaced with silver ions. The silver ion content in the silver-supported zeolite can be, for example, 0.1% by mass to 15% by mass.

The second deodorant component is laponite, silver supported zeolite, zinc oxide, neem leaf extract, iris leaf extract, perilla leaf extract, hydroxypropyl-β-cyclodextrin, sanna extract, tocopherol, dibutylhydroxytoluene, sugarcane extract, loquat leaf It may comprise at least one selected from the second group consisting of extracts, green tea extracts, and combinations thereof. The second deodorizing component is considered to be useful for deodorizing malodor caused by dimethyl trisulfide, among substances causing tension odor.

The second deodorant component is (A) zinc oxide and (B) laponite, silver-supported zeolite, dibutylhydroxytoluene, sugarcane extract, loquat leaf extract, iris root extract, perilla leaf extract, hydroxypropyl-β-cyclodextrin , Sanna extract, green tea extract, and at least one selected from the third group consisting of combinations thereof. According to this combination, the deodorizing effect of the tension odor can be further enhanced.

Zinc oxide can be fine powder. The average particle diameter of zinc oxide can be, for example, 5 μm or less, 3 μm or less, 2 μm or less, 1 μm or less, or 0.5 μm or less.

The main components of the causative substance of the tension odor are allyl mercaptan and dimethyl trisulfide, as will be described later. Both substances have a particularly large impact on the sense of smell. Therefore, if the odors of allyl mercaptan and dimethyl trisulfide are eliminated, the tension odor can be effectively eliminated.

The method of using the deodorant of the present disclosure and the method of deodorizing tension odor will be described.

The deodorant of the present disclosure can be sprayed in the air in advance and / or after the event to a place where a tension odor is generated and / or a place where the tension odor may be generated. The deodorant can be attached or spread on cloth products such as clothes, curtains and carpets in advance and / or after the fact. If the deodorant does not adversely affect the skin, the deodorant can be applied to the skin in advance and / or after the fact. For example, a deodorant can be applied to a place where a tension odor component is considered to be secreted, for example, palm, armpit, foot, back, head, face, oral cavity, and the like.

The deodorant of the present disclosure can be used in combination with other deodorants, those that remove or mitigate bad odors by chemical, biological, physical action and the like. For example, the deodorant of the present disclosure can further contain a deodorizing component, a deodorizing component, another deodorizing component, and the like as long as the effect of the deodorant of the present disclosure is not impaired.

The deodorant according to the present disclosure can eliminate or suppress the discomfort that occurs when smelling a tense odor. Moreover, a person who is or has been in a tension state or a mental stress state, or a person who is likely to become a tension state or a mental stress state in the future generates a tension odor by using the deodorant of the present disclosure. It is possible to eliminate or reduce the anxiety that it may have occurred and the anxiety that it may generate a tense odor in advance and / or after the fact.

The deactivating agent according to the second embodiment of the present disclosure will be described.

The tension odor component has at least one of a psychological activity and a physiological activity on humans. For example, when a person senses a tense odor, or when an olfactory receptor responds to a tense odor component, it becomes clear that the person is mentally fatigued, confused, or awakened. It's getting on. The tension odor component may have a psychoactive activity and / or psychological activity other than these. The inactivating agent of the present disclosure has an effect of inactivating such a mental activity and / or psychological activity of the tension odor component. That is, when a person senses the scent of the inactivation agent of the present disclosure, mixes and smells the scent of the inactivation agent and a tension odor, or when the olfactory receptor responds to the inactivation agent, etc. The person can eliminate or suppress the mental modulation and / or psychological modulation as described above.

Especially, it became clear that negative emotions increased when people perceived a tense odor. It also became clear that positive emotions tend to decline. Negative emotions include, for example, “anger / hostility”, “confused / embarrassed”, “depressed / depressed”, “fatigue / impotence”, and “tension / impotence” based on the POMS (Profile of Mood States) test. Anxiety ”is mentioned. It has been found that the tension odor particularly increases “confused / embarrassed”, “fatigue / apathy” and “tension / anxiety”. Positive emotions include, for example, “liveliness / energy” and “friendship”.

The deactivating agent of the present disclosure includes at least one of a first deactivating component and a second deactivating component.

The first deactivating component can include at least one selected from the first group consisting of silver-supported zeolite, tocopherol, zinc oxide, Kamsnar extract, Lumpuyan extract, and combinations thereof. The first inactivating component is considered to be useful for inactivating malodor caused by allyl mercaptan among causative substances of tension odor.

The second inactivating component is laponite, silver supported zeolite, zinc oxide, neem leaf extract, iris root extract, perilla leaf extract, hydroxypropyl-β-cyclodextrin, sanna extract, tocopherol, dibutylhydroxytoluene, sugarcane extract, loquat At least one selected from the second group consisting of leaf extract, green tea extract, and combinations thereof may be included. The second inactivating component is considered to be useful for inactivating malodor caused by dimethyl trisulfide, among the causative substances of tension odor.

The second inactivating component is (A) zinc oxide and (B) laponite, silver-supported zeolite, dibutylhydroxytoluene, sugarcane extract, loquat leaf extract, iris root extract, perilla leaf extract, hydroxypropyl-β-cyclo Preferably, at least one selected from a third group consisting of dextrin, sanna extract, green tea extract, and combinations thereof. According to this combination, the tension odor inactivating effect can be further enhanced.

Psychologically active and physiologically active effects due to the tension odor component, and inactivation of the tension odor component due to the inactive agent are, for example, a method using a psychological questionnaire such as POMS (registered trademark) (Profile of Mood States). ), GACL (General Activity Checklist) or the like.

The main components of the causative substance of the tension odor are allyl mercaptan and dimethyl trisulfide, as will be described later. Both substances have a particularly large impact on the sense of smell. Therefore, if the odors of allyl mercaptan and dimethyl trisulfide are eliminated, the psychological and / or physiologically active action due to the tension odor can be effectively inactivated.

The method for using the deactivating agent of the present disclosure and the method for deactivating the tension odor component will be described.

The inactivating agent of the present disclosure can be sprayed in the air in advance and / or after the event in a place where a tension odor component is generated and / or a place where it may be generated. The deactivator can also be applied or spread on fabric products such as clothes, curtains and carpets in advance and / or after the fact. If the deactivator does not adversely affect the skin, the deactivator can be applied to the skin in advance and / or after the fact. For example, the deactivator can be applied to a part that is considered to secrete a tense odor component, such as the palm, armpit, foot, back, head, face, oral cavity, and the like.

The inactivating agent of the present disclosure can be used in combination with other psychological and physiological action inactivating agents and the like. For example, the inactivation agent of the present disclosure may further contain another inactivation agent as long as the effect of the inactivation agent of the present disclosure is not inhibited. Other deactivators include, for example, those that remove or mitigate malodors by chemical, biological, physical action, etc. against malodors (eg, tension odors) (eg, deodorant components, deodorant components, deodorant components) Etc.).

The inactivating agent of the present disclosure can inactivate the mental activity and / or psychological activity of the tension odor component. Thereby, psychological modulation, physiological modulation, and the like caused by the tension odor component can be eliminated or suppressed. Persons who are or have been in tension or mental stress, or who are likely to become tension or mental stress, in advance and / or after using the inactivating agent of the present disclosure It is possible to take measures such as psychological modulation and physiological modulation.

The method for producing the deodorant and the deactivator of the present disclosure is not particularly limited. For example, a deodorant and an inactivating agent can be produced by mixing a deodorant component.

The tension odor and the tension odor component referred to in the present disclosure will be described.

¡Tension odor is an odor emitted from the body when nervous or under stress. The tension or mental stress here includes, for example, tension or stress that depends on interpersonal relationships. Interpersonal tension / stress is, for example, the tension / stress that is being announced in public (especially before a large number of people), the tension / stress that is undergoing an important or oppressive interview Etc. In such a mental stress state, for example, when there is no heart rate increase due to exercise, the heart rate per minute is 20 bpm (beats per minute) or more, preferably 30 bpm or more higher than that at normal rest. It can be said that it is in a state. Normal resting means resting without mental stress and a state in which heart rate does not fluctuate, for example, a state of sitting and relaxing for a predetermined time or longer.

The tension odor is considered to be based on the components contained in the blood. In the present disclosure, “generation from the body (secretion / release)” means generation (secretion / release) from the skin, mucous membrane and / or oral cavity. “Body odor” in the present disclosure includes bad breath.

The tension odor component includes a compound containing sulfur element (sulfur compound). Examples of the sulfur compound include at least one of allyl mercaptan and dimethyl trisulfide. Preferably, the tension odor component includes both allyl mercaptan and dimethyl trisulfide.

The allyl mercaptan can be 0.1 ppb or more, 0.3 ppb or more, 0.5 ppb or more, 1 ppb or more, or 10 ppb or more on a volume basis. The allyl mercaptan can be 1,000 ppm or less, 100 ppm or less, 10 ppm or less, 1 ppm or less, 500 ppb or less, 100 ppb or less, or 10 ppb or less on a volume basis.

Dimethyl trisulfide can be 1 ppb or more, 2 ppb or more, 3 ppb or more, 5 ppb or more, 10 ppb or more, 20 ppb or more, 50 ppb or more, or 100 ppb or more on a volume basis. Dimethyl trisulfide can be 10,000 ppm or less, 1,000 ppm or less, 100 ppm or less, 10 ppm or less, 1 ppm or less, 100 ppb or less, or 10 ppb or less on a volume basis.

In the tension odor component, the mass ratio of allyl mercaptan to dimethyl trisulfide is, for example, 2 parts by mass or more, 5 parts by mass or more, 10 parts by mass or more, or 15 parts by mass with respect to 1 part by mass of allyl mercaptan. Part or more. The mass ratio of allyl mercaptan and dimethyl trisulfide is, for example, 50 parts by mass or less, 40 parts by mass or less, 30 parts by mass or less, or 25 parts by mass or less with respect to 1 part by mass of allyl mercaptan. Can do.

Tension odor components include hydrogen sulfide, methyl mercaptan, carbon disulfide, dimethyl sulfide, dimethyl disulfide, methylpropyl trisulfide, and these as sulfur compounds other than allyl mercaptan and dimethyl trisulfide (hereinafter referred to as “other sulfur compounds”). It may further contain at least one compound selected from the group consisting of: The total amount of sulfur compounds can be 0.1 ppb or more, 1 ppb or more, or 10 ppb or more on a volume basis. The total amount of sulfur compounds can be 10,000 ppm or less, or 1,000 ppm or less on a volume basis.

The tension odor component can contain 1-octen-3-one as a non-sulfur compound in addition to or alone with respect to the sulfur compound. 1-octen-3-one can be, for example, 0.1 ppb or more, 0.5 ppb or more, 1 ppb or more, 10 ppb or more, 100 ppb or more, or 1 ppm or more on a volume basis. 1-octen-3-one can be, for example, 1,000 ppm or less, 100 ppm or less, 10 ppm or less, or 1 ppm or less on a volume basis.

The deodorant and deactivator of the present disclosure will be described below with examples. However, the deodorant and the deactivator of the present disclosure are not limited to the following examples.

[Example 1: Deodorization test for dimethyl trisulfide]
Deodorant 0.05 mass% and dipropylene glycol 99.95 mass% were mixed and the deodorizer solution was produced about each deodorizer. 1 mL of the deodorant solution and 5 × 10 ⁻⁴ parts by mass of dimethyl trisulfide with respect to 1 part by mass of the deodorant were injected into a sample tube having a capacity of 30 ml. Three expert panels sniffed the scent in the sample tube and evaluated the deodorizing effect of each deodorant on dimethyltrisulfide according to the following criteria.

[Deodorizing effect on substances causing tension odor]
2 points: Special panel evaluated that deodorant has high deodorizing effect;
1 point: A special panel evaluated that the deodorant has a slightly higher deodorizing effect;
0 point: The expert panel evaluated that there was no deodorant effect of a deodorizer.

Table 1 shows the deodorant tested and the evaluation of the deodorizing effect of each deodorant by a specialized panel. The evaluation shown in Table 1 represents the average score of the specialized panel according to the following criteria. The average particle size of zinc oxide used in the following examples is about 0.2 μm.

A: 2 points;
B: 1.5 points or more and less than 2 points;
C: 1 point or more and less than 1.5 point;
D: Less than 1 point.

The deodorizers in Test Examples 1 to 5 were confirmed to have a deodorizing effect on dimethyl trisulfide, which is a causative substance of tension odor. Therefore, the deodorizers of Test Examples 1 to 5 are considered to be effective for deodorizing tension odors.

[Example 2: Deodorization test for allyl mercaptan]
Deodorizer 0.10 mass% and dipropylene glycol 99.90 mass% were mixed, and the deodorizer solution was produced about each deodorizer. 1 mL of the deodorant solution and 5 × 10 ⁻⁶ parts by mass of allyl mercaptan with respect to 1 part by mass of the deodorant were injected into a sample tube having a capacity of 30 ml. Three expert panels sniffed the scent in the sample tube, and evaluated the deodorizing effect of each deodorant on allyl mercaptan according to the following criteria. Table 2 shows the deodorant tested, and the evaluation of the deodorizing effect by a specialized panel for each deodorant. The evaluation criteria are the same as in Example 1.

The deodorizers of Test Examples 10 to 18 were confirmed to have a deodorizing effect on allyl mercaptan, which is a causative substance of tension odor. Therefore, the deodorizers of Test Examples 10 to 18 are considered to be effective for deodorizing tension odors.

[Example 3: Deodorization test for allyl mercaptan]
Deodorizer 0.10 mass% and dipropylene glycol 99.90 mass% were mixed, and the deodorizer solution was produced about each deodorizer. The deodorizer contains 50% by mass of zinc oxide as component A and 50% by mass of component B shown in Table 3. 1 mL of the deodorant solution and 2.5 × 10 ⁻⁶ parts by mass of allyl mercaptan with respect to 1 part by mass of the deodorant were injected into a 30-ml sample tube. Three expert panels sniffed the scent in the sample tube, and evaluated the deodorizing effect of each deodorant on allyl mercaptan according to the following criteria. Table 3 shows the deodorant tested, and the evaluation of the deodorizing effect by a specialized panel for each deodorant. The evaluation criteria are the same as in Example 1.

When zinc oxide and other deodorant were mixed, the deodorizing effect was generally improved as compared with using the deodorant component alone. For example, comparing Test Examples 10, 16, 22, 23, and 25 shown in Table 2 with Test Examples 26, 32, 37, 38, and 40 shown in Table 3, respectively, the deodorization used in Example 2 By adding zinc oxide to the agent, the deodorizing effect could be enhanced compared to the deodorant alone. For example, laponite, hydroxypropyl-β-dextrin, sugarcane extract, loquat leaf extract, and green tea extract alone had a low deodorizing effect, but the deodorizing effect could be enhanced by mixing with zinc oxide. That is, these deodorizing components and zinc oxide are considered to have a synergistic effect of deodorization. From this, it is thought that mixing of a plurality of types of deodorizing components is more effective for deodorizing tension odors. In particular, a deodorant containing zinc oxide as the second deodorant component is considered to be more effective for deodorizing tension odors.

When comparing Test Example 12 and Test Example 28, the deodorizing effect could be improved by increasing the amount of zinc oxide with respect to the malodor-causing substance. From this, if the application amount of a deodorizer is increased with respect to a tension odor, the deodorizing effect can be improved more.

[Example 4: Deodorization test for tension odor model composition]
Deodorants shown in Table 4 containing zinc oxide as component A and hydroxypropyl-β-dextrin as component B were prepared. Next, the tension odor model composition containing the tension odor component shown in Table 5 was produced. Next, 100 μL of the tension odor model composition and 10 μL of the deodorant were mixed in a 100 mL sealed glass container. Then, after the sealed glass container was allowed to stand for 10 minutes, the gas components present in the upper space of the sealed glass container were directly analyzed by mass spectrometry.

As a result, no tension odor component was detected from the upper space of the sealed glass container in which the deodorant and the tension odor model composition were mixed. The tension odor component is considered to be physically and / or chemically removed from the upper space by being adsorbed by the deodorant. From this, according to the deodorizer of this indication, it was confirmed that a tension odor can be effectively deodorized.

[Example 5: Psychological / mental effect test]
The subject was sniffed with a tension odor model composition, and the psychological and mental changes of the subject due to the tension odor were confirmed using POMS (registered trademark) and GACL. As a result, it was confirmed that when the subject smells a tense odor, arousal, fatigue and confusion occur.

Next, when the deodorant of the present disclosure was sniffed together with the model composition of the tense odor, the subject did not see the psychological and mental changes described above. From this, it was confirmed that the deodorant of this indication can inactivate the psychological and mental action by a tension odor (secretory component).

The following is a detailed description of a test that analyzed psychological state changes using the POMS (registered trademark) 2 adult shortened version (Profile of Mood, States, Second Edition, Adult, and Short) Japanese test paper. In this psychological analysis, based on the answers to the questions, anger / hostility, confusion / embarrassment, depression / depression, fatigue / apathy, and tension / anxiety, which are negative mood indicators, In addition, it is possible to confirm the psychological state related to “liveness / vibration” and “friendship” which are positive mood indexes. There were five questions for each index on the test paper, and each subject was given a score according to the following criteria for the mood presented in each question (maximum score of 20 for each index).

0 points: no mood presented;
1 point: There was a little feeling presented;
2 points: The mood presented was ok;
3 points: There was a lot of feeling presented;
4 points: The feelings presented were very much.

First, eight subjects were in a resting state for 20 minutes. After that, I was asked to answer the question on the above inspection sheet. This inspection is referred to as “inspection 1”.

Next, among the tension odor model compositions shown in Table 6, each subject continued to sniff the tension odor for 5 minutes using the lowest concentration model composition that each subject could recognize. After that, he asked me to answer the same question as in Exam 1. This inspection is referred to as “inspection 2”.

The average value and standard deviation of the scores for each index in the examinations 1 and 2 were calculated. Table 7 shows the results. In FIG. 1, the graph of the average value of a score with respect to each parameter | index and a standard deviation is shown.

Comparing the results of Test 1 and Test 2, as shown in FIG. 1, it was found that negative emotions, particularly tension, confusion, and fatigue, increase by perceiving a tension odor. On the other hand, there was a tendency for positive emotions to decline. From this, it was found that the tense odor has a psychological and mental action that turns human emotions in an unstable direction.

As demonstrated in Example 4 above, the deodorant of the present disclosure can remove the tension odor component. Therefore, according to the deodorant of this indication, it turned out that the negative psychological and mental action resulting from a tension odor can be inactivated (cancellation, reduction, and / or relaxation). That is, it was found that the deodorant of the present disclosure can be applied as an inactivating agent for the psychological and mental effects of a tension odor.

The deodorant and the deactivator of the present disclosure have been described based on the above-described embodiments and examples, but are not limited to the above-described embodiments and examples, and are within the scope of the present invention. Based on the basic technical idea of the invention, various disclosed elements (including elements described in the claims, the specification, and the drawings) can include various modifications, changes, and improvements. In addition, various combinations, substitutions, or selections of the disclosed elements are possible within the scope of the claims of the present invention.

Further problems, objects, and forms (including modified forms) of the present invention will become apparent from the entire disclosure of the present invention including the claims.

The numerical ranges described in this document should be construed as any specific numerical value or range included in the said range, even if not otherwise specified.

Claims

Including at least one of a first deodorant component and a second deodorant component;
The first deodorizing component includes at least one selected from the first group consisting of silver-supported zeolite, tocopherol, zinc oxide, Camsnar extract, Lumpuyan extract, and combinations thereof;
The second deodorant component is composed of laponite, silver-carrying zeolite, zinc oxide, neem leaf extract, iris root extract, perilla leaf extract, hydroxypropyl-β-cyclodextrin, sanna extract, tocopherol, and combinations thereof. The tension odor deodorant containing at least 1 selected from the group of these.
Including at least one of a first deodorant component and a second deodorant component;
The first deodorizing component includes at least one selected from the first group consisting of silver-supported zeolite, tocopherol, zinc oxide, Camsnar extract, Lumpuyan extract, and combinations thereof;
The second deodorant component is
Zinc oxide,
Selected from the third group consisting of laponite, silver supported zeolite, dibutylhydroxytoluene, sugarcane extract, loquat leaf extract, iris root extract, perilla leaf extract, hydroxypropyl-β-cyclodextrin, sanna extract, green tea extract, and combinations thereof A tension odor deodorant, comprising:
The tension odor deodorant according to claim 1 or 2, wherein the tension odor is an odor emitted from the body due to a tension state and / or mental stress.
The tension odor deodorant according to any one of claims 1 to 3, wherein the causative substance of the tension odor includes at least one of allyl mercaptan and dimethyl trisulfide.
The tension odor deodorant according to claim 4, wherein the causative substance further contains at least one compound selected from the group consisting of methyl mercaptan, dimethyl sulfide, dimethyl disulfide, and combinations thereof.
6. The tension odor deodorant according to claim 4 or 5, wherein the causative substance further comprises 1-octen-3-one.
Including at least one of a first deactivating component and a second deactivating component;
The first deactivating component includes at least one selected from the first group consisting of silver-supported zeolite, tocopherol, zinc oxide, Kamsnar extract, Lumpuyan extract, and combinations thereof;
The second inactivating component includes laponite, silver-supported zeolite, zinc oxide, neem leaf extract, iris root extract, perilla leaf extract, hydroxypropyl-β-cyclodextrin, sanna extract, tocopherol, and combinations thereof. Comprising at least one selected from the group of two;
An inactivating agent that inactivates the psychological or mental activity of secretory components.
Including at least one of a first deactivating component and a second deactivating component;
The first deactivating component is at least one selected from the first group consisting of silver-supported zeolite, tocopherol, zinc oxide, Kamsnar extract, Lumpuyan extract, and combinations thereof;
The second inactivating component is
Zinc oxide,
Selected from the third group consisting of laponite, silver supported zeolite, dibutylhydroxytoluene, sugarcane extract, loquat leaf extract, iris root extract, perilla leaf extract, hydroxypropyl-β-cyclodextrin, sanna extract, green tea extract, and combinations thereof At least one of
An inactivating agent that inactivates the psychological or mental activity of secretory components.
The inactivating agent according to claim 7 or 8, wherein the secretory component is a component secreted from the body due to tension and / or mental stress.
The inactivating agent according to any one of claims 7 to 9, wherein the secretory component contains at least one of allyl mercaptan and dimethyl trisulfide.
The inactivation according to any one of claims 7 to 10, wherein the secretory component further comprises at least one compound selected from the group consisting of methyl mercaptan, dimethyl sulfide, dimethyl disulfide, and combinations thereof. Agent.
The inactivating agent according to any one of claims 7 to 11, wherein the secretory component further comprises 1-octen-3-one.